Delivery Order SPE2DB20D7059-SPE2DB25FQJP2
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $3,423.55 and an ultimate completion date of August 19, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,567,089,253 units of Moxifloxacin HCL 400 mg tablets. The award has a ceiling value of $20,097.88 and an ultimate completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for the delivery of moxifloxacin, a 400 mg/250 ml antibiotic medication, with a ceiling value of $1,075.38 and an ultimate completion date of September 3, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,722.55 firm fixed-price delivery order is for 50 units of the medication Moxifloxacin HCl 400 mg Tablet. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of 4,564,763,735 units of Moxifloxacin HCl 400 mg Tablets in 50-count packages. The $8,115.12 firm fixed-price contract was awarded on May 30, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a period of performance through May 31, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,127.06 contract is for the delivery of 4,567,919,068 units of the antibiotic Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,760.00 firm fixed-price delivery order is for the supply of 50 units of 400 mg moxifloxacin HCl tablets, with a completion date of June 26, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, which provides...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4563954862 - moxifloxacin hydrochloride 400 mg tablets. The contract has a ceiling value of $2,010.89 and a period of performance through March 14, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,580,380 units of the medication Moxifloxacin HCl 400 mg Tablet 30s, with a ceiling value of $2,921.13. The contract is a Firm Fixed Price Delivery Order, with a period of performance extending through June 18, 2025. The contract is not set aside and is open to full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,585.38 firm fixed-price delivery order is for the supply of Moxifloxacin Hydrochloride, a broad-spectrum antibiotic medication. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...